0001601830 1 2026-02-25 2026-02-25 0001601830 2026-02-25 2026-02-25 shares pure iso4217:USD 0001601830 Recursion Pharmaceuticals, Inc. 333-284878 S-3 424B5 EX-FILING FEES N/A N/A false Equity Class A Common Stock, par value $0.00001 per share true 300000000 300000000 0.00013810 41430 300000000 41430 0.00 0.00 41430 In accordance with Rules 456(b) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), the registrant initially deferred payment of all of the registration fees for the Registration Statement on Form S-3ASR (File No. 333-284878), filed on February 12, 2025 (the “Registration Statement”). This “Calculation of Filing Fee Table” shall be deemed to update the “Calculation of Registration Fee” table in the Registration Statement. The prospectus to which this Exhibit is attached is a final prospectus supplement for the related offering.